Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments
- Author(s)
- Zhang, E; Nguyen, THO; Allen, LF; Kedzierski, L; Rowntree, LC; Chang, SY; Zhang, W; Habel, JR; Foo, IJ; Menon, T; Mitchell, J; Leong, RW; Bond, K; Williamson, DA; Kedzierka, K; Christensen, B;
- Details
- Publication Year 2024-03-06,Volume 73,Issue #4,Page 712-714
- Journal Title
- Gut
- Publisher
- BMJ
- Keywords
- Covid-19; Immune response; Immunology; Inflammatory bowel disease; Tnf
- Research Division(s)
- Infectious Diseases And Immune Defence
- PubMed ID
- 36878683
- Publisher's Version
- https://doi.org/10.1136/gutjnl-2022-329136
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-03-29 08:34:17
Last Modified: 2024-03-11 10:02:38